franckreporter/iStock via Getty Images
- Applied DNA Sciences (APDN) +116%.
- Poseida Therapeutics (PSTX) +81%.
- Ping Identity Holding (PING) +60%Non-GAAP EPS of -$0.34 misses by $0.22, revenue of $72.03M misses by $1.27M.
- Alnylam Pharmaceuticals (ALNY) +47%as Phase 3 trial for ATTR amyloidosis therapy meet main goal.
- MediaCo Holding (MDIA) +35%.
- AMTD IDEA (AMTD) +25%.
- SemiLEDs (LEDS) +22%.
- Ocean Power Technologies (OPTT) +22%.
- Connexa Sports Technologies (CNXA) +22%.
- Aethlon Medical (AEMD) +24%.
- Rigel Pharmaceuticals (RIGL) +17%Q2 - Results - Earnings Call Presentation.
- Precipio (PRPO) +16%.
- Intellia Therapeutics (NTLA) +15%.
- China SXT Pharmaceuticals (SXTC) +16%.
- Second Sight Medical Products (EYES) +14%.
- PayPal Holdings (PYPL) +13%announces stock selling by selling shareholder.
- Atlas Air Worldwide Holdings (AAWW) +12%likely to be acquired for $102.5/share by Apollo-led group.
- Arcutis Biotherapeutics (ARQT) +12%gains on pricing $150M sock offering.
- SoFi Technologies (SOFI) +11%CEO Anthony Noto on Q2 2022 Results - Earnings Call Transcript.
- Quoin Pharmaceuticals (QNRX) +9%.
- NeuroOne Medical Technologies (NMTC) +10%.
- Faraday Future Intelligent Electric (FFIE) +9%.
- Bionano Genomics (BNGO) +9%.
- Coherus BioSciences (CHRS) +8%on FDA nod for Roche Lucentis' interchangeable biosimilar Cimerli.
- Sierra Wireless (SWIR) +8%as Wedbush downgrades after Sierra Wireless deal.